However, leptin resistance observed in obese individuals potentially disqualifies leptin therapies as a cure to the obesity and type 2 diabetes epidemic (Coppari and Bjørbæk, 2012; Neill, 2013). Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.